Skip to main content

Ileal Interposition with Sleeve Gastrectomy for the Treatment of Type 2 Diabetes

  • Chapter
Metabolic Syndrome and Diabetes

Abstract

Type 2 diabetes mellitus (T2DM) and obesity are predicted to be two of the greatest public health problems of the coming decades globally. Worldwide, the prevalence of Diabetes is increasing and vascular complications are the main cause of death. Indeed, during 1988–2000 the annual all-cause mortality rates among T2DM patients were 25.2 per 1000 person-years compared with 9.5 per 1000 person-years in those without diabetes in the US population age 35–74 years. Cardiovascular (CV) disease mortality in this diabetic population was 11.1 per 1000 person-years compared to 3.4 per 1000 person-years in those without diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fox CS, Coady S, Sorlie PD, D’Agostino Sr RB, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544–50.

    Article  PubMed  Google Scholar 

  2. Gregg EW, Qiuping G, Cheng YJ, Venkat Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147:149–55.

    Article  PubMed  Google Scholar 

  3. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.

    Article  PubMed  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and T2DM after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  5. Adams T, Gress R, Smith S, Halverson C, Simper S, Rosamond W, LaMonte M, Stroup A, Hunt S. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    Article  PubMed  CAS  Google Scholar 

  6. Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, Kashya SR, Kirwan JP, Rogula T, Kroh M, Chand B, Schauer PR. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37.

    PubMed  PubMed Central  Google Scholar 

  7. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with T2DM mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–12.

    Article  PubMed  CAS  Google Scholar 

  8. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335–42.

    Article  PubMed  CAS  Google Scholar 

  9. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.

    Article  PubMed  Google Scholar 

  10. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  Google Scholar 

  11. The VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.

    Article  Google Scholar 

  12. ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  Google Scholar 

  13. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ESH, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

    Article  PubMed  CAS  Google Scholar 

  14. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet III WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Stone HB. Ann Surg. 1928;88(3):593–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Kral JG. Obesity surgery – state of the art. In: Van Itallie TB, Hirsch J, editors. Recent advances in obesity research IV. London: John Libbey; 1985. p. 237–46.

    Google Scholar 

  17. Smithy WB, Cuadros C, Johnson H, Kral JG. Effects of ileal interposition on body weight and intestinal morphology in dogs. Int J Obes. 1986;10:453–60.

    PubMed  CAS  Google Scholar 

  18. Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.

    Article  PubMed  CAS  Google Scholar 

  19. DePaula AL, Macedo ALV, Prudente A, Silva L, Schraibman V, GozaniNeto J, Pinus J, Cury EK, Szajnbok P, DiDario RP, Bertocco L, Diniz K, Gaudencio J, Bebin L, D’Orto U, Cison D, Penhavel F. Neuroendocrine brake for the treatment of morbid obesity. Preliminary report. Einstein. 2005;3(2):110–4.

    Google Scholar 

  20. De Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”). Surg Obes Relat Dis. 2006;2:464–7.

    Article  PubMed  Google Scholar 

  21. Strader AD. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav. 2006;88:277–82.

    Article  PubMed  CAS  Google Scholar 

  22. Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav. 2008;95:271–81.

    Article  PubMed  CAS  Google Scholar 

  23. DeFronzo RA, et al. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes Care. 2009;58(4):773–95.

    Article  CAS  Google Scholar 

  24. DePaula AL, Macedo LAV, Schraibman V, Mota BR, Vencio S. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc. 2009;23:1724–32.

    Article  PubMed  Google Scholar 

  25. Cummings PC, Strader DS, Stanhope KI, Graham JI, Lee J, Raybould HE, Baskin DG, Havel PJ. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the ucd-t2dm rat. Gastroenterology. 2010;138:2437–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Patriti A, Facchiano E, Annetti C, Aisa MD, Galli F, Fanneli C, Donini A. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1256–64.

    Article  Google Scholar 

  27. Patriti A, Alsa MC, Sidoni A, Galli N, Donini A. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced Proglucagon gene expression an L-cell number. Surgery. 2007;142:74–85.

    Article  PubMed  Google Scholar 

  28. Boza C, Munoz R, Yung E, Mizone L, Gagner M. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg. 2011;15:928–34.

    Article  PubMed  Google Scholar 

  29. Zhang GY, Wang TT, Cheng ZQ, Feng JB, Hu SY. Resolution of diabetes mellitus by ileal interposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes. Can J Surg. 2011;54(4):243–51.

    Article  PubMed  PubMed Central  Google Scholar 

  30. DePaula A, Stival A, Halpern A, Vencio S. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg. 2011;35(1):102–8.

    Article  PubMed  Google Scholar 

  31. Celik A, Ugale S, Ofluoglu H, Asci M, Celik BO, Vural E, Aydin M. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25:1184. doi:10.1007/s11695-14-1518-1.

    Article  PubMed  PubMed Central  Google Scholar 

  32. DePaula AL, Stival AS, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m2. Surg Obes Relat Dis. 2010;6:296–305.

    Article  Google Scholar 

  33. DePaula AL, Stival AR, DePaula CCL, Halpern A, Vencio S. Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg. 2012;16(5):967–76.

    Article  PubMed  Google Scholar 

  34. Hari Kumar KVS, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11:785–9.

    Article  Google Scholar 

  35. Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35:2238–44.

    Article  PubMed  Google Scholar 

  36. Goel R, Amin P, Goel M, Marik S. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients. Int J Diabetes Dev Ctries. 2011;31(2):91–6.

    Article  Google Scholar 

  37. Dolan K, Hatzifotis M, Newbury L. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesitiy. Obes Surg. 2004;14:165–9.

    Article  PubMed  Google Scholar 

  38. DePaula AL, Halpern A, Muscelli E, Mari A, Stival A, Vencio V, Ferrannini E. Improvement in insulin sensitivity and b-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg. 2011;15(8):1344–53.

    Article  PubMed  Google Scholar 

Download references

The authors attest that there is no conflict of interest to disclose related to this book chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aureo L. DePaula M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

DePaula, A.L., DePaula, C.C.L., Ugale, S. (2016). Ileal Interposition with Sleeve Gastrectomy for the Treatment of Type 2 Diabetes. In: Kurian, M., Wolfe, B., Ikramuddin, S. (eds) Metabolic Syndrome and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3220-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3220-7_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3219-1

  • Online ISBN: 978-1-4939-3220-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics